Brought to you by
ECR 2013 / C-0702
MSCT in GIST patients with hepatic metastases treated with new generation tyrosinkinase inhibitors: comparison between density and dimension.
Congress: ECR 2013
Poster No.: C-0702
Type: Scientific Exhibit
Keywords: Oncology, Abdomen, Gastrointestinal tract, CT, Contrast agent-intravenous, Staging, Cancer, Metastases, Monoclonal antibodies
Authors: A. Insalaco, G. Lo Re, F. Muscarneri, F. Patti, M. C. Galfano, L. La Grutta, T. V. Bartolotta, M. Midiri; Palermo/IT


Gastro-Intestinal Stromal Tumors (GIST) are the most common tumors of non-epithelial gastrointestinal tract. Since the introduction of molecular targeted drug, there has been increasing concern about the use of the traditional tumor response criteria. Aim of this study is to compare diagnostic effectiveness of functional vs. dimensional criteria, measured by MSCT after contrast medium (c.m.) administration, in the follow-up of GIST metastatic patients receiving new generation Tirosine Kinase inhibitors (TKI).

POSTER ACTIONS Add bookmark Contact presenter Send to a friend Download pdf
2 clicks for more privacy: On the first click the button will be activated and you can then share the poster with a second click.

This website uses cookies. Learn more